Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8617976 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL63212 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL62768 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL8614275 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL3133329 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL4228469 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL62965 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL4123177 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL17997086 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL4265800 | 1.00 | LMNA (0.35) | LMNATHRBCA1CA2MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4310975-B1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, AND NON-AQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY WHICH INCLUDE THE SAME | LG ENERGY SOLUTION LTD (KR) | 2025-02-12 | — | — | EP | disclosed |
| US-20240204249-A1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, AND NON-AQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY WHICH INCLUDE THE SAME | LG ENERGY SOLUTION, LTD. (KR) | 2024-06-20 | — | — | US | disclosed |
| EP-4310975-A1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS ELECTROLYTE COMPRISING SAME, AND LITHIUM SECONDARY BATTERY | LG ENERGY SOLUTION, LTD. (KR) | 2024-01-24 | — | — | EP | disclosed |
| CN-117203816-A | Additive for nonaqueous electrolyte, nonaqueous electrolyte and lithium secondary battery comprising the same | 株式会社LG新能源 | 2023-12-08 | — | — | CN | disclosed |
| WO-2023075379-A1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS ELECTROLYTE COMPRISING SAME, AND LITHIUM SECONDARY BATTERY | 주식회사 엘지에너지솔루션 | 2023-05-04 | — | — | WO | disclosed |
| US-20040067311-A1 | Fluorinated-photoinitiators in dual cure resins | CIBA SPECIALTY CHEMICALS CORP. | 2004-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240204249-A1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, AND NON-AQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY WHICH INCLUDE THE SAME | LAGE3, AQP1, SLC9A1 | LMNA 1882/4885THRB 3603/4885CA1 267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.